Understanding Multifocal Atrial Tachycardia (MAT) on ECG

Introduction

Multifocal Atrial Tachycardia (MAT) is an abnormal heart rhythm characterized by multiple sites within the atria generating electrical signals independently. This leads to a rapid and irregular heart rate.

Causes and Risk Factors

MAT is most commonly associated with: - Chronic lung disease (e.g., COPD) - Electrolyte imbalances (e.g., low potassium, low magnesium) - Heart disease (e.g., heart failure, coronary artery disease) - Medications (e.g., theophylline, beta-agonists) - Sepsis or systemic illness

ECG Features of MAT

On an electrocardiogram (ECG), MAT is diagnosed by: - Heart rate : Generally >100 bpm - Irregular rhythm - P waves with at least three different morphologies - Varying PR intervals - Narrow QRS complexes

How is MAT Different from Atrial Fibrillation?

Both MAT and atrial fibrillation cause irregular heart rhythms, but in MAT, distinct P waves are present, while atrial fibrillation lacks identifiable P waves.

Treatment and Management

  • Address the underlying cause : Correct electrolyte imbalances, manage lung disease, and review medications.
  • Rate control : Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem) are often preferred.
  • Avoid beta-blockers in patients with lung disease due to the risk of bronchospasm.
  • Oxygen therapy and bronchodilators if related to respiratory disease.

When to Seek Medical Help?

If you experience palpitations, dizziness, chest pain, or shortness of breath, seek immediate medical attention.

Conclusion

MAT is a challenging arrhythmia often related to pulmonary disease. Proper identification on ECG and treatment of the underlying condition are key to managing this condition effectively.

Source recommendations

1. American College of Cardiology/American Heart Association (ACC/AHA) Guidelines on Supraventricular Arrhythmias

  1. https://www.ahajournals.org/doi/10.1161/cir.0000000000000311
  2. https://pubmed.ncbi.nlm.nih.gov/14557344/
  3. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2015/09/23/09/13/2015-ACC-AHA-HRS-Guideline-for-the-Management-of-Adult-Patients-With-SVT
  4. https://pubmed.ncbi.nlm.nih.gov/14563598/
  5. https://www.heartrhythmjournal.com/article/s1547-5271(15)01189-3/fulltext

2. European Society of Cardiology (ESC) Guidelines on Supraventricular Tachycardia

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Supraventricular-Tachycardia
  2. https://academic.oup.com/eurheartj/article/41/5/655/5556821
  3. https://pubmed.ncbi.nlm.nih.gov/31504425/
  4. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2019/09/10/12/36/2019-ESC-Guidelines-for-Supraventricular-Tachycardia
  5. https://pubmed.ncbi.nlm.nih.gov/14557344/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow